Glymidine (sodium)
Product Specifications
UNSPSC Description
Glymidine sodium is an oral active antidiabetic. Glymidine sodium is the inhibitor of hepatic lipolysis. Glymidine sodium inhibits the glucose formation and supresses the elevated pyruvate oxidation which results from the inhibition of endogenous lipid mobilization[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/glymidine-sodium.html
Purity
98.48
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=S([N-]C1=NC=C(OCCOC)C=N1)(C2=CC=CC=C2)=O.[Na+]
Molecular Weight
331.32
References & Citations
[1]Menahan LA, et al. The role of endogenous lipid in gluconeogenesis and ketogenesis of perfused rat liver. Eur J Biochem. 1969;9(2):182-188.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-A0231/Glymidine-sodium-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-A0231/Glymidine-sodium-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
3459-20-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
